BVTIQ Recent News Biovest International, Inc. CEO
Post# of 4
Posted On: 03/03/2014 4:48:25 AM
BVTIQ Recent News
Biovest International, Inc. CEO Carlos F. Santos, Ph.D. to Present at the Phacilitate Immunotherapy Forum Business Wire - Mon Jan 27, 6:00AM CST
European Medicines Agency Accepts Marketing Authorization Application for Biovest's Cancer Vaccine for Treatment of Non-Hodgkin's Follicular Lymphoma Business Wire - Mon Jan 13, 6:00AM CST
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Accentia Biopharmaceuticals, Inc. and Certain Officers, and Biovest International, Inc. of Class Action Lawsuit and Upcoming Deadline -- ABPI and BVTIQ GlobeNewswire - Fri Aug 30, 7:58PM CDT
Biovest International, Inc. CEO Carlos F. Santos, Ph.D. to Present at the Phacilitate Immunotherapy Forum Business Wire - Mon Jan 27, 6:00AM CST
European Medicines Agency Accepts Marketing Authorization Application for Biovest's Cancer Vaccine for Treatment of Non-Hodgkin's Follicular Lymphoma Business Wire - Mon Jan 13, 6:00AM CST
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Accentia Biopharmaceuticals, Inc. and Certain Officers, and Biovest International, Inc. of Class Action Lawsuit and Upcoming Deadline -- ABPI and BVTIQ GlobeNewswire - Fri Aug 30, 7:58PM CDT
(0)
(0)Biovest International Inc. (BVTIQ) Stock Research Links
Scroll down for more posts ▼